SCHEMBL9846187

SCHEMBL9846187

CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(SC(C)(C)C)nc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
L-697661 SCHEMBL30432096 0.83 CD38 (0.31)
L-697661 SCHEMBL29456987 0.76 FABP4 (0.34)
L-697661 SCHEMBL599639 0.76 FABP4 (0.34)
SCHEMBL9846215 0.75 FABP4 (0.31)
SCHEMBL9846072 0.71 TYMS (0.32)
SCHEMBL9455992 0.71 HCAR2 (0.33)
SCHEMBL9431504 0.71 MEN1 (0.46)
SCHEMBL9846309 0.70 FABP4 (0.31)
SCHEMBL9283257 0.69 ADRA2A (0.32)
SCHEMBL9171193 0.69 FABP4 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0462800-A2 Inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1991-12-27 EP disclosed